close
MENU
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Investment
3 mins to read

Will anaesthesia prove the next big thing for F&P Healthcare?

Forsyth Barr has upgraded its rating from underperform to neutral after a deep dive on the global anaesthesia market.

FPH's Optiflow Switch

Fiona Rotherham Wed, 24 Apr 2024

Forsyth Barr has upgraded its rating on listed healthcare company F&P Healthcare (FPH) from underperform to neutral after an in-depth look into its prospects for gaining market share in the huge global market for anaesthesia products.

In a research note, analysts Matt Montgomerie and Ben Crozier

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends March 31st

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Wed, 24 Apr 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
F&P Healthcare Forsyth Barr anaesthesia healthcare
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

F&P Healthcare initiates $12m voluntary recall of Airvo devices
Investment

US blow to major sleep device maker not a boon to F&P: analyst
Shoeshine

Has Fisher & Paykel Healthcare’s share price slide ended?
Shoeshine
1

F&P Healthcare investor reality check
Investment

F&P Healthcare says it’s nearly back to normal after Covid surges
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

F&P Healthcare initiates $12m voluntary recall of Airvo devices
Investment

US blow to major sleep device maker not a boon to F&P: analyst
Shoeshine

Has Fisher & Paykel Healthcare’s share price slide ended?
Shoeshine
1

F&P Healthcare investor reality check
Investment

F&P Healthcare says it’s nearly back to normal after Covid surges
Will anaesthesia prove the next big thing for F&P Healthcare?
Investment,
103758
true
Subscribe Login